Navigation Links
Global Bioinformatics Market 2013 - 2017
Date:1/13/2014

DUBLIN, Ireland, January 13, 2014 /PRNewswire/ --


Research and Markets (http://www.researchandmarkets.com/research/gxn8lj/bioinformatics) has announced the addition of the "Global Bioinformatics Market 2013 - 2017" report to their offering. 


     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)


Based on the use of bioinformatics, the various sectors covered in this report are medicine, agriculture, environment, animal, forensic, academics, and others (homeland security and defense, law-enforcement groups, bio-weapon creation, antibiotic resistance, and evolutionary biotechnology). The medical sector accounted for a lions share of the bioinformatics market in 2012. The medical sector has been further classified as molecular medicine, gene therapy, drug discovery and development, clinical diagnostics, and reproductive biotechnology.

The bioinformatics market, by products and services, has been classified as knowledge management tools, platforms, and services. These segments are integral components of application areas such genomics, proteomics, and other life-science research, and are used for the acquisition, development, management, analysis, and integration of huge amounts of data generated during biological research. Knowledge management tools dominated the bioinformatics market in 2012, followed by platforms and services. Knowledge management tools are majorly used by researchers to handle large volumes of heterogeneous information and to integrate them with existing knowledge repositories.

Segments in the bioinformatics application market are genomics, proteomics, chemoinformatics, molecular phylogenetics, metabolomics, transcriptomics, and others (glycomics, cytomics, physiomics and interactomics). Genomics contributes the highest to the bioinformatics market; it is poised to grow at a high CAGR from 2012 to 2017. The application of bioinformatics in genomics is driven by growing pharmacogenomics applications for the discovery of new drugs and characterization of older drugs, development of new bioinformatics tools to handle large sets of data generated through genomics research, and decreasing cost of DNA sequencing. Metabolomics is the fastest-growing application area due to developments in analytical instruments that enable profiling of metabolites with high throughput and accuracy.

North America accounted for the largest market share of the bioinformatics market, followed by Europe, in 2012. This is attributed by an increasing demand for bioinformatics in genomics and proteomics research, technological advancements, growing use of bioinformatics tools in the drug discovery process, and presence of a large number of market players. However, other regions such as Asian and Latin American countries represent emerging markets, owing to a rise in research outsourcing by pharmaceutical giants, increasing number of Contract Research Organizations (CROs), rise in public and private sector investment, and growing industry -academia partnerships.

Major players in the bioinformatics industry include Accelrys, Inc. (U.S.), Affymetrix, Inc. (U.S.), Life Technologies Corporation (U.S.), Illumina, Inc. (U.S.), and CLC bio. (Denmark). 


Key Topics Covered: 

1 Introduction

2 Executive Summary 

3 Market Overview 

4 Global Bioinformatics Market, By Sectors 

5 Global Bioinformatics Market, By Products & Services

6 Global Bioinformatics Market, By Applications 

7 Geographic Analysis

8 Competitive Landscape

9 Company Profiles


Companies Mentioned:

  • Accelrys, Inc
  • Active Motif, Inc
  • Affymetrix, Inc
  • Agilent Technologies, Inc
  • Biomatters, Ltd
  • Biomax Informatics Ag
  • Clc Bio
  • Geneva Bioinfromatics (Genebio) Sa
  • Id Business Solutions Ltd
  • Illumina, Inc
  • Instem Plc
  • Integromics SL
  • Kinexus Bioinformatics Corporation
  • Knome, Inc
  • Life Technologies Corporation
  • Nonlinear Dynamics Ltd
  • Ocimum Biosolutions, Ltd
  • Partek, Incorporated
  • Perkinelmer, Inc
  • Textco Biosoftware, Inc



For more information visit http://www.researchandmarkets.com/research/gxn8lj/bioinformatics


Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Loss of large carnivores poses global conservation problem
2. National Academy of Inventors 2013 Conference showcased global innovation
3. Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies
4. EcoHealth Alliance and Bat Conservation International forge partnership to work on global bat conservation and public health issues
5. Cloud mystery solved: Global temperatures to rise at least 4C by 2100
6. Cloud mystery solved: Global temperatures to rise at least 4°C by 2100
7. UNL research raises concerns about global crop projections
8. Telecoupling science shows Chinas forest sustainability packs global impact
9. Global Cancer Biomarkers Market 2012-2016 with Agilent Technologies Inc., Gen-Probe Inc. and Astellas Pharma US Inc. Dominating
10. Singapore joins global translational medicine network as Asia-Pacific hub
11. Scripps leads first global snapshot of key coral reef fishes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2016)... 2016 --> --> Fourth ... (105.0), up 1,187% compared with fourth quarter of 2014. Gross ... M (loss: 30.0). Earnings per share increased to SEK 6.39 ... M (neg: 74.7). , --> ... SEK 2,900.5 M (233.6), up 1,142% compared with 2014. Gross ...
(Date:2/3/2016)... , Feb. 3, 2016 ... the addition of the "Emotion Detection ... Machine Learning, and Others), Software Tools (Facial ... Areas, End Users,and Regions - Global forecast ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has ...
(Date:2/2/2016)... 2, 2016 Checkpoint Inhibitors for Cancer ... Are you interested in the future of ... checkpoint inhibitors. Visiongain,s report gives those predictions to ... national level. Avoid falling behind in data ... and revenues those emerging cancer therapies can achieve. ...
Breaking Biology News(10 mins):
(Date:2/5/2016)... 2016  In the pharmaceutical industry the medical affairs ... launch activities including the identification and engagement of key ... especially high in the oncology therapeutic area where most ... the Role of Medical Affairs in Oncology Launch Excellence ... therapies find better ways to utilize medical affairs to ...
(Date:2/5/2016)... -- Amarantus BioScience Holdings, Inc. ... products for Regenerative Medicine, Neurology and Orphan Diseases, announced ... from the US Food and Drug Administration (FDA) for ... granted orphan drug designation (ODD) by the US FDA ... Inc. (OTCQB: AMBS), a biotechnology company ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... compliance training, today announced an interactive FDA compliance training course, ... (Regulatory Affairs Professional Society) accredited interactive course on Morf Playbook—now conveniently available on ...
(Date:2/4/2016)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), the ... Edward Lanphier , Sangamo,s president and chief executive officer, ... ZFP Therapeutic ® development programs and an overview ... on Thursday, February 11, 2016, at the Leerink Partners ... is being held in New York ...
Breaking Biology Technology: